The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20201479: Thomas H. Lee Parallel Fund VIII, L.P.; Insurance Technologies Holdings, LLC
20201419: Clayton, Dubilier & Rice Fund XI, L.P.; HD Supply Holdings, Inc.
20201402: BidCo 100 Limited; OneWeb Global Limited
20201407: DiamondPeak Holdings Corp.; Stephen S. Burns
20201409: The Founders Fund II, LP; Palantir Technologies Inc.
20201410: The Founders Fund III, LP; Palantir Technologies Inc.
20201411: The Founders Fund IV, LP; Palantir Technologies Inc.
20201413: Peter Thiel; Palantir Technologies Inc.
20201415: William G. Davis; James J. Arrigo
20201418: Software Acquisition Group Inc.; John S. Hendricks and Maureen D. Hendricks
2006004 Informal Interpretation
Gerber Products Co., doing business as Nestlé Nutrition, et al.
In October 2014, the FTC charged Gerber Products Co. with deceptively advertising that feeding its Good Start Gentle formula to infants with a family history of allergies prevents or reduces the risk that they will develop allergies. The FTC also alleged that Gerber falsely advertised Good Start Gentle’s health claims as FDA-approved. The stipulated court order announced today, which the court has entered as final, settles the FTC’s charges and prohibits Gerber from similar conduct in the future.
Regenerative Medical Group, Inc.
The FTC is mailing 270 checks totaling nearly $515,000 to consumers who paid for what the agency alleged was deceptively advertised “amniotic stem cell therapy” between 2014 and 2017. The average amount each consumer will receive is $1,907.